Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Join the club for FREE to access the whole archive and other member benefits.
Ensuring safety of drugs, medical supplies and food which is used daily.
FDA is an agency within the Department of Health and Human Services.
The FDA's organization consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations.
The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.
The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.
Visit website: https://www.fda.gov/
Login to view link, or join the club to get full access to all resources and other benefits.
Login to view link, or join the club to get full access to all resources and other benefits.
Login to view link, or join the club to get full access to all resources and other benefits.
Login to view link, or join the club to get full access to all resources and other benefits.
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
The Club interviews Jesse Karmazin, CEO, to find out more about the trial, the FDA warning, and the relaunch
Sometimes news coverage of e-cigarettes can be confusing - what's the best advice?
Director of the Center for Devices and Radiological Health at the FDA.
Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration
American physician and investor.
Dr. A. Abernethy is a Principal Deputy Commissioner and Acting CIO at US FDA
pharmaphorum - 22-Aug-2021
Prior study approval and monitoring long-term outcomes are needed to ensure patient's safety
Read more...Lifespan.io (LEAF) - 28-Jul-2021
Discusses animal trials, potential human trials, reeducating the FDA and improvements in technology
Read more...BBC - 08-Jun-2021
A long way from a cure, but hopefully indicates that Alzheimer's isn't unassailable
Read more...FiercePharma - 21-Aug-2020
A good example of why you have to be careful buying meds - even big pharma has problems.
Read more...The times of Israel - 15-Jul-2020
Don't try this at home! Too much oxygen (hyperoxia) is definitely bad for you
Read more...New York Times - 27-May-2020
Found only in extended-release versions of metformin, immediate-release versions are okay
Read more...Newsweek - 14-May-2020
Study and procedure represent a milestone in personalized medicine for Parkinson's
Read more...AACC (American Association for Clinical Chemistry) - 01-May-2020
Huge potential in a more personalized diagnostics and diet-based disease interventions
Read more...TechCrunch - 29-Apr-2020
BBC was blown away at CES so let's hope this helps bring this "iPhone of wearables" to market
Read more...Longevity Vision Fund - 20-Apr-2020
To support human clinical trial of novel encapsulated cell therapy for hemophilia A
Read more...WebMD - 03-Apr-2020
May cause serious adverse effects if stem cells over attack normal lung cells
Read more...University of California, Berkeley - 30-Mar-2020
In response to mass testing needs, they employ robotics and automation for accuracy and speed
Read more...Medical Futurist - 19-Mar-2020
Risk prediction and best therapy for a specific patient is a future possibility
Read more...The Scientist - 01-Mar-2020
Including the latest on clinical trials of first-generation senolytics
Read more...The Verge - 13-Dec-2019
This closed-loop system customizes treatment, automatically adjusts insulin levels
Read more...Washington Post - 28-Nov-2019
CBD products developing companies are frustrated with the FDA's lack of of clear regulations
Read more...Fight Aging! - 08-Oct-2019
Will this increase the tendency towards young blood transfusion?
Read more...Aging - 04-Oct-2019
Detailed history and review of current understanding of Rapamycin and longevity
Read more...Harvard Health Publishing - 02-May-2019
The high rate of alerts and warnings maybe the result of post-approval monitoring
Read more...NeurologyLive - 25-Apr-2019
50% improvement in complications of therapy, 19.2% in motor examinations and more
Read more...